Lastest Stories by Fintel Staff

Dan Loeb’s Third Point has sold about a quarter of its Cano Health stake.
An activist fund run by Elliott Management veteran Quentin Koffey has disclosed a Delaware lawsuit to block changes to Masimo's bylaws.
Carlson Capital has filed a 13D form with the US Securities & Exchange Commission that it doubled its stake in Glatfelter above 10%.
These past few weeks have been a busy period for the Edmonton headquartered weed producer and retailer Aurora Cannabis.
Eleven insiders have bought more than 5 million shares of this clinical-stage biopharmaceutical company over the past 90 days.
Nine out of 10 stock traders with accounts at Charles Schwab believe a U.S. recession is very likely.
Warren Buffett and Berkshire Hathaway (US:BRK.A, US:BRK.B) spent more than $40 billion this year buying large chunks of several companies’ shares after keeping their powder dry during the height...
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.